ALB vs TWST · rev $1.74B vs rev $332.8M
Albemarle Corp (ALB) versus Twist Bioscience Corp (TWST) — a side-by-side from cached financials, not a winner call.
Albemarle Corp (ALB) is a specialty chemicals company listed on US.
Twist Bioscience Corp (TWST) is a diagnostics & research company listed on NASDAQ.
Latest reported ALB revenue for 2026-06-30 was $1.74B. Net income was $480.0M. Revenue was up 22.0% from 2026-03-31 to 2026-06-30. ALB currently screens at market cap $8.00B.
Latest reported TWST revenue for 2026-06-30 was $332.8M. Net income was -$109.6M. Revenue was up 55.2% from 2026-03-31 to 2026-06-30. TWST currently screens at market cap $5.16B.
ALB currently screens at market cap $8.00B. TWST currently screens at market cap $5.16B.
Not investment advice. Open the ALB and TWST stock pages for the full models.
Not investment advice.